FINDINGS:
Comparison: 2023-08-19.
Pulmonary parenchyma: No focal consolidation or suspicious pulmonary nodules. No pneumothorax.
Mediastinum: Enlarged right hilar lymph node, short axis 15 mm. Cardiomediastinal contours within normal limits.
Pleura/Pleural spaces: No pleural effusion or pleural thickening.
Great vessels/Aorta: No thoracic aortic aneurysm or dissection. aorta normal caliber.
Liver: No focal hepatic lesions. Normal attenuation.
Spleen: Normal in size and attenuation. No focal splenic lesion.
Pancreas: Normal pancreatic contour and enhancement. No focal mass. pancreas is normal.
Adrenal glands: Adrenal glands are normal without nodules. adrenal glands normal.
Kidneys: No hydronephrosis. No enhancing renal mass. Bosniak I cyst.
GI tract/Bowel: 10 mm irregular mass involving the transverse colon with focal wall thickening (hyperenhancing). No obstructive process. No focal bowel wall mass identified. no colonic mass.
Mesentery/Omentum: No ascites. No omental caking. no peritoneal nodularity.
Mesenteric vessels (SMA/SMV): SMA/SMV are patent without thrombosis.
Urinary bladder: Unremarkable.
Reproductive organs: No adnexal mass. Uterus/prostate within expected size for age.
Lymph nodes: Enlarged celiac lymph node, short axis 9 mm. Enlarged internal iliac lymph node, short axis 30 mm. No pathologically enlarged lymph nodes by size criteria.
Bones/Osseous structures: No aggressive osseous lesion. No acute fracture.

IMPRESSION:
- Colon primary malignancy at transverse colon measuring approximately 10 mm.
- Findings concerning for nodal involvement.
- No definite distant metastases identified.
- RECIST 1.1 Summary:
- Target lesions (n=3; ≤2 per organ rule applied).
  • T1: Primary — 18→10 mm (longest diameter).
  • T2: Lymph node — 26→15 mm (short axis).
  • T3: Lymph node — 15→9 mm (short axis).
- SLD baseline: 59 mm.
- SLD current: 34 mm (-42.4% change).
- New lesions: absent (unequivocal).
- - RECIST 1.1 overall response category: PR.
